DearColleague.us

Letter

Bonnie Watson Coleman

From the office of:

Bonnie Watson Coleman

Sending Office: Honorable Bonnie Watson Coleman
Sent By:
Liz.Lee@mail.house.gov

        Request for Signature(s)

Fight Endometrial Cancer and the
Disparities in Mortality from this Lethal Disease

Endorsed by: Society of Gynecologic Oncology (SGO)

Fill out form
HERE
 to add your boss by MARCH 6TH COB.

Dear Colleague:

Endometrial cancer is the most common gynecological cancer and its incidence in the United States has risen from 40,000 to over 60,000 new cases in the past 10 years. The American Cancer Society estimates that in 2020 there will be approximately 65,620 new
cases of endometrial cancer and approximately 12,590 women will die from this disease.

Endometrial cancer is the fourth most common malignancy among women in the United States, trailing only breast, lung and colorectal cancers. This cancer is slightly more common in white women, but black women are more likely to die from it.

This is why the Congressional Caucus on Black Women and Girls respectfully requests that you join us in requesting inclusion of the report language below in the Fiscal Year 2021 Defense Appropriations bill to ensure endometrial cancer is added to
the Department of Defense Congressionally Directed Medical Research Program Peer Reviewed Cancer Research Program list of research priorities.

 

More Background on Endometrial Cancer

Survival rates for endometrial cancer have remained stagnant while other cancers have shown reductions in the number of deaths. Greater prevalence of key risk factors, such as obesity and shifts in reproductive trends among women, including
delayed childbirth and having fewer children, are believed to be contributing to the increased incidence. While endometrial cancer has been reported to be 31% lower among black patients compared to white women,
the age-adjusted mortality among black women is approximately 84% higher.

Of the total U.S. military active duty personnel, over 213,00 are women, constituting about 16 percent of the total force. Black women now constitute nearly one third of all women in the U.S. armed forces. We owe it to these women to purse critical research
that will produce scientific advancements and understanding about endometrial cancer and facilitate strategies to address the rise in incidence and the disparities in treatment and mortality.

The Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP) supports research across the full range of science and medicine, with an underlying goal of enhancing the health, care, and well-being of military service
members, Veterans, retirees, and their family members. We are hopeful that adding endometrial cancer to the list of research priorities under the PRMRP will renew and strengthen the research effort on this devastating disease. 

Please have your staff fill out this form to join us in requesting that the Defense subcommittee include endometrial cancer as a research priority in the DoD PRMRP. 
The DEADLINE to
sign this letter
is C.O.B. on March 6th

 

If you have any questions and/or want to sign, please contact Liz Lee in Congresswoman Bonnie Watson Coleman’s office at:
liz.lee@mail.house.gov or 6-7295.

 

Sincerely,

/s/

Bonnie Watson Coleman
Co-Chair

/s/

Yvette Clarke
Co-Chair

/s/

Robin L. Kelly
Co-Chair, and
Chair of the Congressional Black Caucus Health Braintrust

 

LETTER TEXT

Dear Chairman Visclosky and Ranking Member Calvert:

As you work to develop the Fiscal Year (FY) 2021 Defense Appropriation bill, we write to request inclusion of the attached report language to ensure that endometrial cancer is added to the Department of Defense Congressionally Directed Medical Research Program
Peer Reviewed Cancer Research Program as a research priority through report language accompanying the Fiscal Year 2021 Defense Appropriations bill.

Endometrial cancer is the most common gynecological cancer, and the 4th most common malignancy among women in the United States. Its incidence in the United States has risen from 40,000 to over 60,000 new cases in the last 10 years; meanwhile, investments
in research into endometrial cancer has stagnated. Alarmingly, the American Cancer Society (ACS) estimates that in 2020 there will be approximately 65,620 new cases of endometrial cancer (this includes endometrial cancers and uterine sarcomas) and approximately
12,590 women will die from this disease.

Further, ACS statistics reveal that survival rates for endometrial cancer have remained stagnant while other cancers have shown reductions in the number of deaths. While the age-adjusted incidence of endometrial cancer is 31% lower among black patients,
the age-adjusted mortality among black women is 84% higher than white women.[1]We are confident that you also find this stark disparity unacceptable; this is why we are requesting inclusion of the attached report
language.

As the over 213,00 women who are U.S. military active duty personnel account for about 16 percent of the total force, we believe this is not a cancer that can be ignored. Further, black women now constitute nearly one third of all women in the U.S. armed
forces.[2]  We owe it to these women to pursue critical research that will produce scientific advancements and understanding about endometrial cancer and facilitate strategies to address the rise in incidence and
the disparities in treatment and mortality.

In closing, we want to thank you for your past support of the Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP), which supports research across the full range of science and medicine, with an underlying goal of enhancing the health,
care, and well-being of military service members, Veterans, retirees, and their family members. It is our hope that adding endometrial cancer to the list of research priorities under the DoD PRMRP will renew and strengthen the research effort on this devastating
disease. 

Thank you for your consideration of this request, and your continued support of PRMRP. 

 

Sincerely,

 

Encl: Text of proposed report language


[1] Ries LAG, Eisner MP, Kosary CL, eds, et al. SEER cancer statistics review, 1973–1998. Bethesda, MD: National Cancer Institute; 2001. [Google Scholar]

[2] Eileen Patten and Kim Parker, Women in the U.S. Military: Growing Share, Distinctive Profile, Pew

Research Center, 2011, http://www.pewsocialtrends.org/2011/12/22/women-in-the-u-s-military-growingshare-distinctive-profile/; Office of the Assistant Secretary of Defense for Personnel and Readiness, Department of Defense, Population Representation in the
Military Services Annual Report, 2013.

 

REPORT LANGUAGE TEXT

Peer Reviewed Cancer Research Programs – Endometrial Cancer

Recognizing the emerging need for new investments to investigate the changing profile of endometrial cancer, as well as the persistently high mortality disparity in black women, the Committee recommends the funds provided in the peer-reviewed cancer research
program are directed to be used to also conduct research on endometrial cancer.

Related Legislative Issues

Selected legislative information:Appropriations, Family Issues, HealthCare

icon eDC logo e-Dear Colleague version 2.0
 
e-Dear Colleagues are intended for internal House use only.